Biotechnology Therapeutics and Diagnostics (NORDIC) - Industry Report

Biotechnology Therapeutics and Diagnostics (NORDIC) - Industry Report

Plimsoll Publishing’s Biotechnology Therapeutics and Diagnostics (NORDIC) Analysis provides a detailed overview of the Biotechnology Therapeutics and Diagnostics (NORDIC) market and delivers a comprehensive individual analysis on the top 100 companies, including AFFITECH RESEARCH AS, AXELAR AB and CANTARGIA AB.

This report covers activities such as pharmaceuticals, drugs, medicines, pills, healthcare and includes a wealth of information on the financial trends over the past four years.

Plimsoll Publishing’s latest Biotechnology Therapeutics and Diagnostics (NORDIC) analysis is ideal for anyone wanting to:

• See the market leaders
• Identify companies heading for failure
• Seek out the most attractive acquisition
• Analyse industry trends
• Benchmark their own financial performance

Using Plimsoll’s exclusive methodology, a quick glance of this Biotechnology Therapeutics and Diagnostics (NORDIC) report will tell you that 53 companies have a declining Plimsoll financial rating, while 32 have shown good sales growth.

Each of the largest 100 companies is meticulously scrutinised in an individual assessment and analysed using the most up-to-date and current financial data.

Every business is examined on the following features:

• The Plimsoll Chart: A graphical assessment of a company’s financial performance
• Four year assessment of the profit/loss and balance sheet
• A written summary highlighting key performance issues

Subsequently, you will receive a thorough 100-page market analysis highlighting the latest changes in the Biotechnology Therapeutics and Diagnostics (NORDIC) market.

This section includes:

• Best Trading Partners
• Sales Growth Analysis
• Profit Analysis
• Market Size
• Rankings

Established in 1987, Plimsoll provides busy managers with a set of tools to monitor the financial welfare of their company, their rivals, or those they wish to acquire. The reports are used to assess the attractiveness of potential acquisitions, gain better understanding of a market and identify sound companies with whom to trade.